Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice

@inproceedings{Luijtgaarden2008PromisesAC,
  title={Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice},
  author={A.C.M. van de Luijtgaarden and J.W.J. de Rooy and L. F. de Geus-Oei and W. van der Graaf and W. J. G. Oyen},
  booktitle={Cancer imaging : the official publication of the International Cancer Imaging Society},
  year={2008}
}
A correct histological diagnosis, careful staging and detection of tumour response to treatment are all crucial in the management of sarcomas. Imaging is important in all of these stages. Sarcomas have distinct biological and treatment-related features posing challenges for imaging. For example, size measurements may not adequately reflect response rates. Techniques which can measure tissue function rather than generate merely anatomical data such as positron emission tomography (PET) are… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
0 Citations
85 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 85 references

Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate

  • S Shankar, E van Sonnenberg, J Desai, PJ Dipiro, A Van Den Abbeele, GD. Demetri
  • Radiology
  • 2005
Highly Influential
13 Excerpts

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

  • AT van Oosterom, I Judson, J Verweij
  • Lancet
  • 2001
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…